{"database": "openregs", "table": "dockets", "rows": [["FDA-2005-P-0057", "FDA", "Revise FDA's guidance entitled labeling for combined oral contraceptives so that the labels of  combined oral contraceptives have warnings relating to the risk of thromboembolic disease that are consistent with those required by European Medicines Agency", "Nonrulemaking", "2021-09-01T01:01:13Z", "0b0000648043ee0a"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-P-0057"], "units": {}, "query_ms": 0.36232592537999153, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}